We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Genomes Project Releases Data to Provide Database for 2,500 Human Genomes

By LabMedica International staff writers
Posted on 21 Jul 2010
The completion of three pilot projects designed to determine how best to build an exceptionally detailed map of human genetic variation begins a new phase in the international project called 1,000 Genomes.

"Mapping all the shared normal variation in human populations is a critical step to interpreting medically actionable genetic changes,” said Dr. More...
Richard Gibbs, director of the Baylor College of Medicine (BCM) Human Genome Sequencing Center (Houston, TX, USA), which is a major contributor to the effort, also a professor in the department of molecular and human genetics at BCM.

The 1,000 Genomes Project began in 2008 with the commencement of three pilot programs. Completion of the pilots launches the full-scale effort to build a public database of human genetic variation from the genomes of 2,500 people from 27 populations worldwide. With the announcement, groups involved in the project placed their final data in freely available databases that can be used and accessed by the worldwide research community.

"The 1000 Genomes Project has a simple goal: peer more deeply into the genetic variations of the human genome to understand the genetic contribution to common human diseases,” said Dr. Eric D. Green, director of the National Human Genome Research Institute, which provides major funding to the effort. "I am excited about the progress being made on this resource for use by scientists around the world and look forward to seeing what we learn from the next stage of the project.”

Recent studies looking for variations that contribute to common human ailments, such as heart disease and diabetes, indicate that a host of rare variations account for much of the burden of disease in the human population. Complex and detailed maps such as those to be assembled from the project provide a potent tool for identifying those rare variations.

The pilot program tested the viability of three strategies. BCM designed and coordinated the approach that involved targeting the sequencing to gene coding regions. This project provided the most complete data for the exons of 1,000 genes, as it was designed to sample deeply the DNA in each of nearly 700 individuals. An estimated 2% of the human genome is composed of protein-coding genes. "We also developed new methods to target variation in genes, and showed that this approach gave maximum information about this important class of human variation,” said Dr. Fuli Yu, an assistant professor in the BCM Human Genome Sequencing Center and coordinator of the study.

The project's fast pace was made possible only by next-generation sequencing technology, which can produce thousands or millions of sequences rapidly. The techniques allow researchers to evaluate all the rare variants found in areas of the genome known to be associated with human disease.

Another of the pilot projects involved using a variety of sequencing technologies to sequence the genomes of six people (two nuclear families including parents and one daughter) at high coverage (meaning in exacting detail). Each sample was sequenced from 20 to 60 times, uncovering a more complete picture of DNA variation in these families. Using different technologies scientists also obtained a better understanding of the strengths of each sequencing platform.

The other pilot project sequenced the genomes of 179 people in less detail--subjecting each sample to an average of approximately four sequencing passes. Researchers then combined the data from different people to discover which genetic variants they share. This technique will provide valuable information in uncovering those genomic variations shared among people or populations.

Researchers can obtain the data freely through the 1000 Genomes website or from the NCBI or the EBI (please see Related Links below). Researchers with limited computing power will be able to access the data through Amazon Web services through the company's Elastic Compute Cloud (AmazonEC2). The database contains all forms of variation found in the genome from single changes called single nucleotide polymorphisms (SNPs), to small insertions and deletions (of genetic material) to the large changes in the structure and number of copies of chromosomes called copy number variations.

In addition to the Baylor College of Medicine Human Genome Sequencing Center, much of the pilot work was carried out by researchers at the Wellcome Trust Sanger Institute (UK), BGI Shenzhen in China, the Broad Institute of Massachusetts Institute of Technology (MIT; Cambridge, MA, USA), and Harvard (Cambridge, MA, USA); the Washington University Genome Sequencing Center at the Washington University School of Medicine (St. Louis, MO, USA); and Boston College (MA, USA).

Related Links:

Baylor College of Medicine Human Genome Sequencing Center
1,000 Genomes Project
NCBI data
EBI Data



Gold Member
Troponin T QC
Troponin T Quality Control
Serological Pipet Controller
PIPETBOY GENIUS
New
Modular Hemostasis Automation Solution
CN Track
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.